GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Cash Conversion Cycle

Qlife Holding AB (OSTO:QLIFE) Cash Conversion Cycle : 1,416.40 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Qlife Holding AB's Days Sales Outstanding for the three months ended in Sep. 2023 was 1416.4.
Qlife Holding AB's Days Inventory for the three months ended in Sep. 2023 was 0.
Qlife Holding AB's Days Payable for the three months ended in Sep. 2023 was 0.
Therefore, Qlife Holding AB's Cash Conversion Cycle (CCC) for the three months ended in Sep. 2023 was 1,416.40.


Qlife Holding AB Cash Conversion Cycle Historical Data

The historical data trend for Qlife Holding AB's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB Cash Conversion Cycle Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Cash Conversion Cycle
- 164.10 -14.56 -48.56

Qlife Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.85 47.29 691.05 1,494.71 1,416.40

Competitive Comparison of Qlife Holding AB's Cash Conversion Cycle

For the Medical Devices subindustry, Qlife Holding AB's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qlife Holding AB's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Cash Conversion Cycle falls into.



Qlife Holding AB Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Qlife Holding AB's Cash Conversion Cycle for the fiscal year that ended in Dec. 2022 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=38.65+104-191.21
=-48.56

Qlife Holding AB's Cash Conversion Cycle for the quarter that ended in Sep. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=1416.4+0-0
=1,416.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qlife Holding AB  (OSTO:QLIFE) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Qlife Holding AB Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Qlife Holding AB (OSTO:QLIFE) Business Description

Traded in Other Exchanges
Address
Redaregatan 48, Helsingborg, SWE, SE-252 36
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines